Previous 10 | Next 10 |
Lantheus Holdings ([[LNTH]] +9.3%) is likely to record its biggest one-day gain since April 2020 after announcing the acquisition of exclusive, worldwide rights to develop, manufacture and commercialize NTI-1309, a PET oncology imaging agent from Noria Therapeutics.NTI-1309 that tar...
Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find, Fight and Follow serious medical conditions, announced today it has acquired the...
- Statistically Significant Correlation Between Biomarker Responses and Objective Tumor Response - Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artifici...
OSPREY Phase 2/3 Results Published in the Journal of Urology CONDOR Phase 3 Results Published in Clinical Cancer Research Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics,...
Lantheus Holdings, Inc. (LNTH) Q4 2020 Earnings Conference Call February 25, 2021 04:30 PM ET Company Participants Mark Kinarney - Senior Director of Investor Relations Mary Anne Heino - President and CEO Bob Marshall - Chief Financial Officer Conference Call Participants Anthony Petrone - Je...
The following slide deck was published by Lantheus Holdings, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: Lantheus Holdings, Inc. 2020 Q4 - Results - Earnings Call Presentation
Image source: The Motley Fool. Lantheus Holdings Inc (NASDAQ: LNTH) Q4 2020 Earnings Call Feb 25, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Lantheus Holdings Inc (LNTH) Q4 2020 Earnings Call Transcript
Lantheus (LNTH): Q4 Non-GAAP EPS of $0.07 beats by $0.06; GAAP EPS of -$0.05.Revenue of $94.2M (+5.4% Y/Y) beats by $2.79M.Press Release For further details see: Lantheus EPS beats by $0.06, beats on revenue
Worldwide revenue of $94.2 million and $339.4 million for the fourth quarter and full year 2020, representing an increase of 5.4% and a decline of 2.3% over the prior year period, respectively Net loss of $3.4 million and $13.5 million for the fourth quarter and full yea...
Lantheus (NASDAQ:LNTH) is scheduled to announce Q4 earnings results on Thursday, February 25th, after market close.The consensus EPS Estimate is $0.01 (-97.1% Y/Y) and the consensus Revenue Estimate is $91.41M (+2.3% Y/Y).Over the last 2 years, LNTH has beaten EPS estimates 100% of the time a...
News, Short Squeeze, Breakout and More Instantly...
Lantheus Holdings Inc. Company Name:
LNTH Stock Symbol:
NASDAQ Market:
Lantheus Holdings Inc. Website:
2024-08-01 08:00:12 ET David Turkaly from JMP Securities issued a price target of $125.00 for LNTH on 2024-08-01 07:13:00. The adjusted price target was set to $125.00. At the time of the announcement, LNTH was trading at $104.83. The overall price target consensus is at...
Second Quarter 2024 Worldwide revenue of $394.1 million, an increase of 22.5% from second quarter 2023 Completed three strategic transactions to expand innovative pipeline GAAP fully diluted earnings per share of $0.88, compared to $1.33 in second quarter 2023. Adjusted fully ...
BEDFORD, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, July 31, 2024, to discuss its financial and operating results for the second...